These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1260 related items for PubMed ID: 27050206
1. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ. N Engl J Med; 2016 Apr 07; 374(14):1344-55. PubMed ID: 27050206 [Abstract] [Full Text] [Related]
2. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH. Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):58-66. PubMed ID: 12007942 [Abstract] [Full Text] [Related]
6. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine. Webre C, Shonka N, Smith L, Liu D, De Groot J. Anticancer Res; 2015 Oct 27; 35(10):5467-72. PubMed ID: 26408710 [Abstract] [Full Text] [Related]
9. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. Buckner JC, Gesme D, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R. J Clin Oncol; 2003 Jan 15; 21(2):251-5. PubMed ID: 12525516 [Abstract] [Full Text] [Related]
10. [Chemo-radiotherapy for malignant brain tumors]. Kochi M, Ushio Y. Gan To Kagaku Ryoho; 2002 May 15; 29(5):669-76. PubMed ID: 12040669 [Abstract] [Full Text] [Related]
11. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW. Clin Cancer Res; 2003 Mar 15; 9(3):981-90. PubMed ID: 12631596 [Abstract] [Full Text] [Related]
14. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study. Brandes AA, Tosoni A, Vastola F, Pasetto LM, Coria B, Danieli D, Iuzzolino P, Gardiman M, Talacchi A, Ermani M. Cancer; 2004 Nov 01; 101(9):2079-85. PubMed ID: 15372474 [Abstract] [Full Text] [Related]
16. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta MP. J Clin Oncol; 2012 Sep 01; 30(25):3065-70. PubMed ID: 22851558 [Abstract] [Full Text] [Related]
17. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ. Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1109-15. PubMed ID: 10613302 [Abstract] [Full Text] [Related]
18. Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Mehta M, Curran W, Radiation Therapy Oncology Group (RTOG), North Central Cancer Treatment Group (NCCTG), Southwest Oncology Group (SWOG), National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), Eastern Cooperative Oncology Group (ECOG). Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):662-9. PubMed ID: 19783377 [Abstract] [Full Text] [Related]
20. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1147-52. PubMed ID: 15001257 [Abstract] [Full Text] [Related] Page: [Next] [New Search]